The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com



Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Mar. 29, 8:39 AM

Slide #12. Stevanato Group S.p.A. Secondary Offering

Company: Stevanato Group S.p.A. (NYSE:STVN)
Date announced: 3/20/2024
Shares Offered: 12,700,000
Date of Pricing: 3/21/2024
Price Per Share: $26.00
Secondary Offering Details: Stevanato Group S.p.A. (NYSE:STVN) ("Stevanato Group," or the "Company"), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares. -updated 3/21- Stevanato Group S.p.A. (NYSE:STVN) ("Stevanato Group," or the "Company"), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its upsized underwritten public offering of an aggregate of 12,700,000 of its ordinary shares at a public offering price of $26.00 per share. Stevanato Group is offering 6,350,000 ordinary shares (the "Company Offering"), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the "Selling Shareholder"), which currently holds approximately 78% of Stevanato Group's outstanding ordinary shares, is offering 6,350,000 ordinary shares (the "Selling Shareholder Offering" and, together with the Company Offering, the "Offering"). Stevanato Group and the Selling Shareholder have granted the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase up to 1,905,000 additional ordinary shares on the same terms and conditions.

Stevanato Group is engaged in the design, production and distribution of products and processes to provide integrated solutions for pharma and healthcare, leveraging on constant investment and the acquisition of skills of new technologies that has brought to become a global player in the pharma industry. Principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, glass forming machines. Co. operates its business in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering.
Open the STVN Page at The Online Investor »

Company Name:  Stevanato Group SpA
Website:  www.stevanatogroup.com
Sector:  Shipping
Number of ETFs Holding STVN:  2
Total Market Value Held by ETFs:  $1.09M
 

Open the STVN Page at The Online Investor (in a new window) »

March 29, 2024    8:39 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree STVN Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.33 out of 4)
46th percentile
(ranked lower than approx. 54% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.